ASH 2021: Impact of Platelet Transfusion on Pulmonary Function of Hematology Oncology Patients: The PIPER Study
Runtime: 5 min
“Impact of Platelet Transfusion on Pulmonary Function of Hematology Oncology Patients: The PIPER Study”
Allison Wheeler, MD
Associate Medical Director, Blood Bank and Coagulation Laboratory – Vanderbilt University Medical Center
Dr. Allison Wheeler of Vanderbilt University Medical Center discusses results from the PIPER Phase 4 Study – the largest study of platelet transfusion associated pulmonary injury to-date with >10,000 platelet components transfused in >2,000 patients.
PIPER, or “Pathogen Inactivated Platelets Entering Routine Practice,” compares the pulmonary safety of conventional and pathogen reduced platelet components transfused to hematology-oncology patients.
View Dr. Wheeler’s presentation originally presented at the 63rd ASH Annual Meeting, December 2021